Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 4

Sex Differences in Trauma, Inflammation and Brain Function and the Implications for Treatment Efficacy in Alcohol Use Disorder

Milky Kohno · with Portland VA Medical Center · NCT06426303

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–60 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 4
Target enrollment
100
US sites recruiting
1
Study start
May 2, 2024
Record last updated
October 6, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The goal of this clinical trial is to identify sex-specific biomarkers that confer greater susceptibility for Alcohol Use Disorder (AUD) and differentiate how treatment response varies by sex in people with Alcohol Use Disorder.

The main questions it aims to answer are

  • How does trauma affect emotion regulation, inflammation, and limbic function, and what are the sex-dependent effects of NTX (Naltrexone) on these aspects?
  • What is the mechanism of Naltrexone (NTX), and how does it potentially moderate reductions in alcohol use through changes in or interactions between emotion regulation, inflammation, or limbic system function?

Participants will

  • Be consented and will undergo comprehensive screening for eligibility criteria
  • Complete behavioral assessments and neuropsychological assessments, as well as neurocognitive assessments and neuroimaging measures
  • Provide urine samples for a urine drug screen (UDS) and urine pregnancy test (for women), and have blood and a cheek swab collected and stored in the repository
  • Take a study drug once daily for 12 weeks and track drug usage and effects in a study journal
  • Undergo weekly assessment calls and bi-weekly medical follow-up safety exams

Researchers will compare naltrexone to placebo in AUD to see if naltrexone is effective in reducing alcohol cravings and promoting abstinence.

Researchers will also compare baseline measures between AUD and Healthy Controls.

Being studied: Naltrexone

Conditions: Alcohol Use Disorder

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • 18-60 years old
  • Veteran enrolled in VHA healthcare

Alcohol Group

  • must meet diagnosis for recent alcohol-use disorder (DSM-V)
  • willing to return for follow-up visits and can participate for 12-weeks

Control Group

  • must not meet DSM-V criteria for a use disorder other than nicotine

Exclusion Criteria

  • Clinically significant neurological, endocrine, hepatic, or systemic disease that would compromise safe participation or confound outcomes
  • Left-handedness
  • Axis-1 psychiatric diagnoses other than anxiety, depression or post-traumatic stress disorder
  • Recreational or prescriptive use of psychotropic medications
  • Recreational or prescriptive use of opioid medications or have a past or current history of abuse or dependence on opioids
  • MRI contraindications (e.g. metal in body)
  • Positive urine drug screen, except for nicotine and marijuana, on test days
  • Women who are pregnant or breastfeeding
  • Participants on hormonal therapy or treatments other than pregnancy contraceptives
  • Autoimmune or neurodegenerative diseases that present with neuroinflammation (multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer's, Parkinson's)
  • Current participation in an investigational drug study
  • Alcohol group: \< 5 days and > 3 weeks of abstinence from alcohol
  • Alcohol group: Liver disease requiring medication or medical treatment, and/or aspartate or alanine aminotransferase levels greater than 3 times the upper limit of normal, gastrointestinal or renal disease that would significantly impair absorption, metabolism or excretion of study drug, or require medical treatment.
  • Non-english speaker

Recruiting US locations

  • VA Portland Health Care System

    Portland, OR 97239

    Site contact: Jazryn Nagum · 503-721-7964 · vhaporhoffmanlab@va.gov

Study contacts (from the official record)

  • Jazryn Nagum · 503-721-7964 · vhaporhoffmanlab@va.gov
All healthy volunteers studies in Oregon →
Sex Differences in Trauma, Inflammation and Brain Function and the… (NCT06426303) | Bored Studies